Merrimack Pharmaceuticals, Inc. (MACK)
(Delayed Data from NSDQ)
$5.90 USD
+0.05 (0.85%)
Updated May 3, 2019 03:59 PM ET
After-Market: $5.84 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For MACK
-
Merrimack Reports Third Quarter 2023 Financial Results
-
Merrimack Reports Second Quarter 2023 Financial Results
-
Merrimack Reports First Quarter 2023 Financial Results
-
Merrimack Reports Third Quarter 2022 Financial Results
-
Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4
-
Merrimack (MACK) Down 7.5% Since Last Earnings Report: Can It Rebound?
-
Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q3
-
Merrimack (MACK) Up 6.7% Since Last Earnings Report: Can It Continue?
-
Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2
-
Merrimack (MACK) Reports Wider-than-Expected Q2 Loss
-
Is a Beat in the Cards for Merrimack (MACK) in Q2 Earnings?
-
Why is Merrimack (MACK) Up 6.3% Since Its Last Earnings Report?
-
Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1
-
Merrimack (MACK) Reports Wider-than-Expected Q1 Loss
-
What's in the Cards for Merrimack (MACK) in Q1 Earnings?
-
Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4
-
What's in the Cards for Merrimack (MACK) in Q4 Earnings?
-
Merrimack (MACK) Down 7.8% Since Earnings Report: Can It Rebound?
-
Merrimack (MACK) Q3 Loss Narrower than Expected, Stock Up
-
Merrimack's (MACK) Reports Narrower-than-Expected Q3 Loss
-
What's in the Cards for Merrimack (MACK) in Q3 Earnings?
-
Merrimack (MACK) Q2 Loss Wider than Expected, Stock Falls
-
Merrimack's (MACK) Reports Wider-than-Expected Q2 Loss
-
What's in the Cards for Merrimack (MACK) in Q2 Earnings?
-
Why Is Merrimack (MACK) Down 57.6% Since the Last Earnings Report?